Surety Medicine

Last Updated: September 26, 2019
Man in hazmat suit

​Surety medicine focuses on protecting the health of the personnel who deal with nuclear, biological or chemical materials, and on medical requirements compliance to help ensure the security of the materials.

October 2019 Surety Medicine Teleconference

VISION CONSERVATION AND READINESS: 

THE COMPETENT MEDICAL AUTHORITY PERSPECTIVE

Wednesday, 16 October 2019 will bring the next monthly Surety Medicine Tele-conference, at 1 pm (1300 hrs) Eastern Time.  The topic for October is “Vision Surveillance.”  The presenter is an Occupational Vision Optometrist assigned to
the Tri-Service Vision Conservation and Readiness Program at the Army Public Health Center. 

To request additional information, email the Army Public Health Center Surety Medicine Program at: usarmy.apg.medcom-aphc.mbx.surety-medicine@mail.mil.


      SCHEDULE OF UPCOMING SURETY MEDICINE TELECONFERENCES 

                                                                    (subject to change):

20 NOV 2019          The Behavioral Health Specialist and the PRP

18 DEC 2019          Red Blood Cell Cholinesterase Monitoring

15 JAN 2020           Pregnancy and the PRP:  Assessing Workplace Hazards

19 FEB 2020           Case Studies in Surety Medicine

18 MAR 2020          Respirator Clearance and PPE Assessments: 
                                The Role of Use Testing

15 APR 2020          Obstructive Sleep Apnea: Diagnosis, Treatment and
                                Presonnel Reliability Program Compliance

20 MAY 2020          Screening for Active Tuberculosis or LTBI

17 JUN 2020          Key Stakeholders in ASAP and SUDCC: Developing         
                               a Competent Medical Authority Alliance

15 JUL 2020           Diagnosis and Treatment of Laboratory-Acquired
                               Tularemia Infection

19 AUG 2020          Regulatory Updates: CPRP, BPRP, and NPRP

23 SEP 2020          Opioids and the PRP: What Every CMA Should Know


--ALERT--

Auto-Injector Shelf Life Extension: 

       NERVE AGENT ANTIDOTE SHELF LIFE EXTENSION PROGRAM

The US Food and Drug Administration (FDA) is alerting health care professionals and emergency responders that specific lots of DuoDote(R) combined nerve agent antidote auto-injectors have been approved for shelf life extensions beyond labeled expiration dates, some are now extended to 2022. 

Previously extended DuoDote(R) Nerve Agent Autoinjector Kit Lots 9AE306, 9AE307, 9AE356, 9AE545, 9AE548, 9AE636 and 9AE645 all expired on or before 30 June 2019.  Lot 9AE835 expires 30 September 2019, and lots 0AE158 and 0AE159 reach their extended expiration date 31 December 2019. Check any auto-injector medication stores you have.  Select the link below for additional information.

Complete FDA information related to the auto-injector shelf life extension program can be found at this  FDA Drug Safety Page.

Information on this page also includes the latest updates on shelf life extensions for the AtroPen(R) (atropine), CANA (diazepam), morphine sulfate, and pralidoxime chloride auto-injectors, with dates listed.